Serina Therapeutics, Inc. Sale of Stock, Consideration Received on Transaction
Serina Therapeutics, Inc. (SER) had Sale of Stock, Consideration Received on Transaction of $5.20 million as of 2026-04-08, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2026-08-13
- Serina Therapeutics, Inc. sale of stock, consideration received on transaction for the quarter ending 2025-03-31 was $5.00M.
| Period end | Sale of Stock, Consideration Received on Transaction | Sale of Stock, Consideration Received on Transaction 3 month |
|---|---|---|
| 2026-04-08 | $5.20M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $5.00M 10-Q · filed 2025-05-08 | |
| 2024-11-26 | $10.00M 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |